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04 The Journal of Thoracic and Cardiobjectives: Comparison of doxorubicin uptake, leakage and spatial regional blood
ow, and drug distribution was made for antegrade, retrograde, combined antegrade
nd retrograde isolated lung perfusion, and pulmonary artery infusion by endovas-
ular inflow occlusion (blood flow occlusion), as opposed to intravenous adminis-
ration in a porcine model.
ethods: White pigs underwent single-pass lung perfusion with doxorubicin
320 g/mL), labeled 99mTc-microspheres, and Indian ink. Visual assessment of the
nk distribution and perfusion scintigraphy of the perfused lung was performed.
9mTc activity and doxorubicin levels were measured by gamma counting and
igh-performance liquid chromatography on 15 tissue samples from each perfused
ung at predetermined localizations.
esults: Overall doxorubicin uptake in the perfused lung was significantly higher
P  .001) and the plasma concentration was significantly lower (P  .0001) after
ll isolated lung perfusion techniques, compared with intravenous administration,
ithout differences between them. Pulmonary artery infusion (blood flow occlu-
ion) showed an equally high doxorubicin uptake in the perfused lung but a higher
ystemic leakage than surgical isolated lung perfusion (P  .0001). The geometric
oefficients of variation of the doxorubicin lung tissue levels were 175%, 279%,
26%, and 151% for antegrade, retrograde, combined antegrade and retrograde
solated lung perfusion, and pulmonary artery infusion by endovascular inflow
cclusion (blood flow occlusion), respectively, compared with 51% for intravenous
dministration (P .09). 99mTc activity measurements of the samples paralleled the
oxorubicin level measurements, indicating a trend to a more heterogeneous spatial
egional blood flow and drug distribution after isolated lung perfusion and blood
ow occlusion compared with intravenous administration.
onclusions: Cytostatic lung perfusion results in a high overall doxorubicin uptake,
hich is, however, heterogeneously distributed within the perfused lung.
solated lung perfusion (ILP) with cytostatic drugs is an attractive treatment
concept for malignancies affecting the lung because it allows for a higher
loco-regional cytostatic drug delivery with lower drug concentration in the
ystemic circulation compared with intravenous (IV) administration. It has been
valuated in clinical1-8 and experimental8-12 settings in this respect. Cytostatic I
as been shown to result in significantly higher drug concentration in lung tissue and
ignificantly lower concentration in plasma compared with systemic drug adminis-
ration.8 However, the results emerging from clinical trials have not shown a
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G
TSurvival advantage in patients with pulmonary malignan-
ies, irrespective of the cytostatic agent administered. One
xplanation for this may be a heterogeneous spatial regional
lood flow and distribution of the cytostatic agent during
ung perfusion.
The current study was designed to compare different
ytostatic ILP techniques with respect to the spatial distri-
ution of 99mTc-labeled microspheres and doxorubicin lev-
ls within the perfused lung in a porcine model. Antegrade
LP (a-ILP) (perfusion through the pulmonary artery), ret-
ograde ILP (r-ILP) (perfusion through the pulmonary
eins), combined antegrade and retrograde ILP (c-ILP), and
ytostatic pulmonary artery infusion with inflow occlusion
f the pulmonary artery by a percutaneously placed balloon




umor-free white pigs underwent a-ILP, r-ILP, or c-ILP isolated
erfusion of the left lung. Each group consisted of 3 animals.
hree animals had cytostatic pulmonary artery infusion with in-
ow occlusion of the pulmonary artery by a percutaneously placed
alloon catheter (blood flow occlusion [BFO]), and 3 animals had
V administration of the perfusate. The perfusate consisted of
00 mL of 6% buffered hetastarch (HAES 6%, Fresenius, Stans,
witzerland) with 160 mg doxorubicin (320 g/mL), 111 MBq
9mTc-labeled microspheres, and 1% ink of India.
nimals and Housing
hite pigs with a body weight of 25 kg were used. All animals
eceived humane care and were treated in accordance with the
nimal Welfare Act, the National Institute of Health “Guidelines
or the Care and Use of Laboratory Animals,” and the guidelines
f the Local Ethical Committee of the University of Lausanne.
solated Lung Perfusion
nduction of anesthesia was performed by intramuscular adminis-
ration of ketamine (10 mg/kg body weight) followed by IV
entothal (10 mg/kg). After tracheal intubation, anesthesia was
aintained with 0.50%  0.05% halothane and 70% nitrous oxide
uring ventilation. Continuous IV infusion of fentanyl 5 g · kg · h
nd pancuronium 0.5 mg · kg · h was performed. The lungs were
Abbreviations and Acronyms
a-ILP antegrade isolated lung perfusion
BFO  blood flow occlusion
c-ILP combined antegrade and retrograde isolated
lung perfusion
IV  intravenous
ln  natural logarithm
r-ILP  retrograde isolated lung perfusionentilated with a volume-controlled ventilator with positive end- t
The Journal of Thoracicxpiratory pressure of 3 to 4 cm H2O throughout and therefore
uring lung perfusion. The tidal volume was 10 mL/kg, and
entilation frequency was adjusted to maintain PACO2 between 4.5
nd 5.5 kPa. All animals were placed on a heating pad while body
emperature was maintained at 38°C. The ventilated gas and IV
uids were at room temperature.
A standard median sternothoracotomy extending to the right
eck and into the left chest was performed. The right carotid artery
nd jugular vein were dissected out, and an arterial and central
enous 6F catheter were inserted for arterial blood pressure mon-
toring, fluid perfusion, drug administration, and collection of
lood samples. The hilar structures of the left lung were dissected,
nd the left pulmonary artery and superior and inferior pulmonary
eins were individually dissected, encircled, and proximally
lamped after IV administration of heparin (2 mg/kg). A custom-
ade silicon cannula was introduced into the pulmonary artery
fter arteriotomy. The inferior and superior pulmonary veins were
eparately cannulated with 2 identical cannulae that were joined
ith a Y-connector during infusion.11
Single-pass, gravity-driven perfusion was performed. The bag
ontaining the perfusion solution was positioned 50 cm above the
evel of the animal’s heart, and the bag and the inflow cannula
ere connected using a light-shielded standard perfusion tube.
oth lungs were ventilated during perfusion. a-ILP consisted of
dministration of the perfusate (500 mL) through the pulmonary
rtery over 20 minutes and collection of the effluent through the 2
enous cannulae. r-ILP consisted of the administration of the
erfusate through the pulmonary veins (250 mL each) over 20
inutes and collection of the effluent by the arterial cannula. c-ILP
onsisted of the administration of 250 mL of the perfusate through
he pulmonary artery over 10 minutes and 250 mL through the
ulmonary veins over 10 minutes. The animals were sacrificed
t the end of the perfusion, and the perfused and nonperfused
ungs were harvested for visual inspection and assessment of
9mTc activity and doxorubicin tissue concentration measure-
ents, respectively.
ytostatic Lung Perfusion by Endovascular Blood
low Occlusion Technique
nesthesia, ventilation, dissection, and catheterization of the ca-
otid artery and jugular vein (without sternotomy) were performed
s previously described. A right-sided groin dissection was per-
ormed, and a Swan-Ganz catheter was introduced into the femoral
ein. The tip of the catheter was placed at the level of the proximal
eft pulmonary artery under fluoroscopic control. The balloon of
he Swan-Ganz catheter was inflated, which led to occlusion of the
roximal left pulmonary artery, and on-table pulmonary angiog-
aphy was performed to confirm the correct position of the cath-
ter. Five-hundred milliliters of the perfusate was administered as
 single-pass gravity-driven perfusion over 20 minutes12 through
he catheter distal to the inflated balloon. After completion of the
erfusion, on-table pulmonary angiography was repeated to con-
rm the correct position of the catheter. The catheter was
emoved, and the femoral vein was ligated. The animals were
acrificed, and the lungs were harvested for visual inspection,
ssessment of 99mTc activity, and doxorubicin tissue concen-
ration measurements.
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TSntravenous Administration of the Perfusate (Controls)
nduction of anesthesia, dissection, and cannulation of the carotid
rtery and jugular vein was performed as previously described.
xygen (2-4 L/min) was supplied by a use of a mask during
pontaneous respiration. Five-hundred milliliters of the perfusate
ere administered through the catheter placed in the jugular vein
y gravity. The animals were sacrificed, and the perfused and
ontralateral lungs were harvested.
ssessment of the Spatial Perfusion Pattern by Ink
taining and Perfusion Scintigraphy
fter sacrifice of the animal, the whole perfused and contralateral
onperfused lungs were harvested. The pattern of ink distribution
f the entire perfused lung was assessed by visual inspection and
hoto documentation of the visceral, mediastinal, and diaphrag-
atic pleura of the perfused lung. The perfused lung was cut in
alf through the hilum and displayed as an “open book.” Perfusion
cintigraphy of both lungs was then performed with a -camera.
ifteen lung tissue samples were harvested in each perfused lung
t predetermined locations according to a mapping as shown in
igure 1. 99mTc activity was assessed in a quantitative manne
ach sample by gamma-counting followed by storing them at
80 °C for doxorubicin concentration measurements.
ssessment of Doxorubicin Concentration in Lung
issues and the Systemic Circulation
ystemic blood samples were collected in 5.5-mL EDTA
-Monovettes (Sarstedt, Nümbrecht, Germany) at 0, 5, 15, and 20
inutes for a-ILP, r-ILP, and c-ILP. The duration of the BFO and
V administrations was longer, and the blood samples were taken
ith an adapted schedule at 0, 5, 10, 15, and 30 minutes. The
amples were stored on ice before centrifugation within 2 hours at
500g for 10 minutes at 4°C. The plasma was snap-frozen at
80°C. The harvested lung tissue samples were frozen after 99mTc
ctivity measurements and stored at 80 °C. Doxorubicin con-
entration measurements were performed by high-performance
igure 1. Mapping for lung tissue harvesting. Each perfused lung
as cut in half through the hilum and displayed as an “open
ook.” Fifteen samples were harvested according to the map for
9mTc activity and doxorubicin concentration measurements.iquid chromatography as previously described.13 l
06 The Journal of Thoracic and Cardiovascular Surgery ● Auguvaluation of Doxorubicin Distribution in the Lung
issue: Data Presentation and Statistics
ecause the tissue concentrations of doxorubicin are distributed
ccording to a log-normal distribution, the calculations and statis-
ics have been done after transformation of the data in their natural
ogarithm (ln). The doxorubicin mean tissue concentration in the
erfused lung was calculated for each pig separately and for each
reatment group and expressed as geometric means:
Geometric mean (Clung or Ctreat) emeanIn data
here mean(ln data) corresponds to the mean of the ln-transformed
ata. Clung is the mean doxorubicin concentration in the lung tissue
or a pig, and Ctreat is the mean doxorubicin concentration in the
ung tissue for a treatment group.
The homogeneity of doxorubicin distribution was evaluated by
alculating the variance of the doxorubicin tissue levels in each
erfused lung separately (s2lung), and by calculating the intra-lung
ariance for each treatment group (s2intra-lung). s2intra-lung repre-
ents the mean variance of the doxorubicin levels of each lung
eparately (s2lung) for a treatment group. The overall variance
s2tot) of a treatment group can be described as follows:
S tot
2  S intra-lung
2  S intra-lung
2
here s2intra-lung corresponds to the variance between the lungs of a
reatment group, that is, the inter-lung variance. Because s2intra-lung
hould not be the result of the treatment effect, only the s2intra-lung
as calculated to describe adequately the variability of the doxo-
ubicin distribution for a treatment group.
Then, as for the mean concentrations, the variances were ob-
ained from the ln-transformed data and back-calculated, applying
he exponential function, to get the geometric coefficients of vari-
tion (CV,%). CVlung (%) is the geometric coefficient of variation
or each lung separately, and CVintra-lung (%) is the intra-lung
eometric coefficient of variation for a treatment group:
CV(%) es In data2  1 ● 100
here: s2(ln data) corresponds to the variance of the ln-transformed
ata
s In data2  sdIn data, these corresponding standard
eviation.
esdIn data  pd, the corresponding percent deviation
CV%  (pd  1) ● 100
For statistical analysis, a 1-way completely randomized design
nalysis of variance was performed with the software Statistix
ersion 8.0 for Windows (Analytical Software, Tallahassee, Fla).
tatistical analysis was run with the ln-transformed data of (1)
lung and (2) s2lung to determine the treatment effect on the (1)
oxorubicin lung levels (Ctreat) and (2) homogeneity of doxorubi-
in distribution (CVintra-lung). If the criteria for a statistical differ-
nce were met, the Tukey’s all-pairwise comparison test was
erformed to find out which groups differ from the others.
esults
ssessment of the Perfusion Pattern by Ink Staining
nd Perfusion Scintigraphy
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G
TSll animals for all modes of perfusion assessed. The most
omogeneous perfusion was found after IV administration.
he spatial distribution of ink was neither anatomic (lobar or
egmental) nor explained by a hydrostatic gradient (Figure
erfusion scintigraphy of the lung also revealed a heteroge-
eous pattern of 99mTc activity within the lung parenchyma
ithout correlation with anatomic (lobar or segmental)
tructures. 99mTc activity measurements of each harvested
ample revealed a marked heterogeneity for all modes of
erfusion assessed (Figure 3) without correlation to a
omic structures or a hydrostatic gradient.
oxorubicin Concentration Time Profile in Plasma
he concentration time profile of doxorubicin in plasma is
hown in Figure 4. The maximum concentration of d
ubicin in plasma was significantly lower (100 times) after
LP than after IV and BFO administration (P  .0001)
ithout differences between the ILP techniques applied. There
as no significant difference in plasma doxorubicin concen-
rations between IV administration and BFO perfusion.
oxorubicin Distribution in the Perfused Lung
able 1 shows the mean lung tissue levels and their
etric coefficients of variation with respect to the mode of
ung perfusion depicted from the analyses of the 15 samples
arvested from each perfused lung. With all treatment
odes, there was a large variability in the doxorubicin lung
issue levels indicating a heterogeneous distribution of
oxorubicin throughout the lung. There was no statistical
ignificant difference between the different modes of per-
usion (a-ILP, r-ILP, c-ILP, and BFO) with respect to doxo-
ubicin lung tissue levels and the variability of doxorubicin
issue distribution. In contrast, a trend to a more homoge-
eous doxorubicin distribution within lung tissue was seen
fter IV administration (P .09). However, IV doxorubicin
dministration resulted in significantly lower drug tissue
igure 2. Visualization of ink staining after c-ILP demonstrating
eterogeneous perfusion pattern not related to anatomy (lobar or
egmental) or hydrostatic gradient. This heterogeneity was sim-
larly observed after each of the perfusion techniques.evels compared with ILP (P  .001). b
The Journal of Thoracic-
orrelation Between 99mTc Activity and Doxorubicin
issue Levels
here was a significant correlation between 99mTc activity
nd doxorubicin level measurements in the different tissue
amples of the perfused lung, for each mode of perfusion
ssessed (P  .01). The correlations (r) were 0.55, 0.73,
.76, 0.61, and 0.77 for a-ILP, r-ILP, c-ILP, BFO, and IV
dministration, respectively (Figure 5).
omment
everal publications have demonstrated the feasibility of
ytostatic ILP in clinical trials.1-8 Various cytostatic regi-
ens were tested including doxorubicin,1,3,7 melphalan,5
latinum,2,4 and tumor necrosis factor- combined with
nterferon-.6 The major indication for ILP was pulmon
etastases, and several reports considered complete metas-
asectomy before4 or after ILP.2,5 All trials demonstrated
xcellent separation between systemic and pulmonary cir-
ulations with minimal or undetectable systemic levels of
ytostatic agents. ILP resulted in acceptable toxicity in
atients and effectively delivered high doses of the cyto-
tatic agent to the perfused lung. However, the clinical
esponse was modest in those trials in which no metasta-
ectomy was performed, which is in contrast with the results
btained after cytostatic limb perfusion14 or cytostatic ILP
n a rodent model with sarcoma lung metastases.8,9 Effec-
ive shielding of the tumor tissue from the delivered drug or
neven drug distribution within the perfused lung may be
esponsible for these disappointing results after cytostatic
LP in patients.
Our experimental study was designed to study the spatial
attern of pulmonary blood flow and drug distribution ac-
ording to the mode of perfusion technique applied in
omparison with IV drug administration. The IV adminis-
ration was performed during spontaneous breathing be-
ause it should reflect as closely as possible the clinical
ontext of IV application of a cytostatic agent.
Most of the experimental work on ILP has been per-
ormed on a tumor-bearing rodent model allowing the as-
essment of a diversity of antineoplastic agents.8 However,
he size of the lung in this model does not easily allow the
ssessment of the spatial pattern of blood flow and drug
istribution during ILP, which requires the harvesting of
arious tissue samples at different localizations of the per-
used lung. A tumor-free porcine model was therefore used
n this respect, which has been used for ILP.8,11,12 A similar
echnique as described by Glenny and colleagues15,16 has
een applied for the assessment of regional blood flow and
oxorubicin distribution for different techniques of cyto-
tatic lung perfusion.
Retrograde ILP has the theoretic potential to perfuse the
arts of the lung supplied by both the pulmonary and
ronchial artery. This might result in a more homogeneous
and Cardiovascular Surgery ● Volume 132, Number 2 307
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G
TSFigure 3. 99mTc activity measurements for each tissue sample harvested according to the mapping of Figure 1. A, a-ILP.
B, r-ILP. C, c- ILP. D, BFO. E, i.v. administration. The left and right hemi-circle represent the lowest and highest.
99mTc activity measured in each treatment group, respectively. The results demonstrate a marked heterogeneity of
99mTc activity for all modes of perfusion assessed.
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G
TSrug delivery to all structures of the perfused lung. r-ILP has
een assessed for paclitaxel-based ILP in sheep combined
ith hyperthermia and has been demonstrated to be feasible
ABLE 1. Mean doxorubicin lung tissue levels and their
eometric coefficient of variation for each animal (Clung and
Vlung) and each treatment group (Ctreat and CVintra-lung), re-
pectively, for antegrade, retrograde, combined antegrade
nd retrograde isolated lung perfusion, pulmonary artery










-ILP 158 244% 289 175%
405 195%
377 86%
-ILP 589 84% 260 279%
199 416%
150 349%
-ILP 417 236% 272 226%
260 234%
186 209%
FO 577 129% 445 151%
279 129%
547 195%
V 56 46% 42* 51%
31 49%
44 58%
IV group was found to be statistically different from the other groups by
ukey’s all-pairwise comparison test (P  .001). a-ILP, Antegrade isolated
ung perfusion; r-ILP, retrograde isolated lung perfusion; c-ILP, combined
ntegrade and retrograde isolated lung perfusion; BFO, blood flow occlu-dion; IV, intravenous.
The Journal of Thoracicnd associated with a substantial pharmacokinetic advan-
age compared with IV administration.10 In addition, result
merging from retrograde flushing of the donor lungs with
he preservation solution during the procurement of the graft
or lung transplantation suggest that there is improved flow
o the airways compared with antegrade flushing.17 Com-
ined ILP allows the delivery of the perfusate to the pul-
onary arteries and veins and has been used during lung
ransplantation.18
Cytostatic lung perfusion with pulmonary artery infusion
nd inflow occlusion by a percutaneously placed balloon cath-
ter (BFO)8,12,19,20 has 2 theoretic advantages. First it co
lleviate any changes in perfusion pattern caused by the sur-
ery itself. Second it allows repeated regional chemotherapy
elivery without operation. Cisplatin-based BFO has been
ompared with ILP in a porcine model with lower lung and
igher systemic drug levels and a more heterogeneous drug
istribution compared with ILP.19 In a previous experiment
tudy, we compared doxorubicin-based ILP with BFO in a
orcine model.12 Overall drug uptake was similar after b
echniques, but BFO resulted in higher doxorubicin plasma
oncentrations than ILP. However, disappointing results were
btained in clinical trials using the BFO technique.20
This experimental study revealed that all methods of ILP
howed an excellent separation of the systemic and pulmo-
ary circulations, and increased drug uptake of the perfused
ungs compared with IV administration. Although r-ILP or
-ILP may theoretically result in an increased leakage be-
ause of retrograde flushing of the bronchial arteries, the
lasma doxorubicin concentrations after r-ILP and c-ILP
ere not different from a-ILP in this model. r-ILP or c-ILP
Figure 4. Plasma doxorubicin
concentration time profile after a-
ILP:‘, r-ILP: , c-ILP: , BFO: ,
and IV administration: Œ.id not show an increased overall drug uptake compared
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G
TS ith a-ILP, but the bronchial circulation represents only 5%
f the pulmonary circulation. BFO resulted in a similar
verall doxorubicin uptake in the perfused lung but revealed
significantly higher systemic leakage as observed after
LP. However, the small number of animals per group and
he wide variation of mean drug lung tissue levels for each
nimal (CVlung) and each treatment group (CVintra-lung) ren-
er identification of any significant difference between
ethods of cytostatic perfusion difficult.
We found a significant correlation between 99mTc ac-
ivity and doxorubicin level for each lung specimen in all
reatment groups, indicating that doxorubicin distribution
orrelates with regional blood flow during ILP. However,
ll methods of cytostatic perfusions (including BFO)
esulted in a marked spatial heterogeneity of regional
9mTc activity and doxorubicin levels in the perfused
ung tissues, which was neither anatomic (lobar or seg-
ental) nor explained by a hydrostatic gradient. These
ifferences were apparent both macroscopically and mi-
roscopically. In contrast, IV administration resulted in a
ess heterogeneous (but not homogeneous) 99mTc activity
nd doxorubicin distribution within lung tissue but also
n significantly lower drug tissue levels compared with
LP and BFO.
Spatial heterogeneity of regional blood flow during ILP
ay be related to anesthetic and ventilatory management,he presence of ventilation-perfusion mismatch and hypo- b
10 The Journal of Thoracic and Cardiovascular Surgery ● Auguhermia caused by thoracotomy and manipulation of the
ung, and acute changes of oxygen tension.15,21,22 Despite
he avoidance of sternotomy and manipulation of the lung
uring BFO, the spatial regional blood flow and drug dis-
ribution in the perfused lung was as heterogeneous as after
LP. We speculate that the heterogeneous spatial blood flow
nd doxorubicin distribution in the perfused lung after BFO
ay be related to (1) a hypoxia-induced regional redistri-
ution of blood flow (caused by a temporary occlusion of
he pulmonary artery), (2) an acute vascular reactivity of the
ulmonary blood vessels exposed to the concentrated per-
usion solution leading to localized vasoconstriction and to
consecutive redistribution of pulmonary blood flow, and
3) a difference in anesthetic and ventilatory management
ompared with IV administration (absence of myorelaxant,
ndotracheal intubation, and controlled ventilation in the IV
roup).
A wide inter-animal variation was not only observed for
he overall doxorubicin uptake in the perfused lungs but also
ith respect to the regional 99mTc activity and doxorubicin
evels in the perfused lung tissues, for all experimental
roups assessed. IV administration also resulted in a marked
nter-animal variability of regional blood flow and drug
istribution with a geometric coefficient of variation for
rug tissue levels of 51% for that treatment group. Previous
xperiments have studied the pattern of regional pulmonary
Figure 5. Relationship between
doxorubicin concentration and
99mTc activity in the samples
collected in the perfused lungs
after ILP, BFO, and IV adminis-
tration: ‘ a-ILP, r  0.55; 
r-ILP, r  0.73;  c-ILP, r  0.76;
BFO, r  0.6; and Œ IV, r 
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G
TSmarked spatial heterogeneity of regional perfusion over
ime that varied between animals.15 However, a heteroge-
eous spatial pattern of pulmonary blood flow distribution
as also found under physiologic conditions in standing
wake dogs, which was stable over days suggesting inho-
ogeneous pulmonary blood flow distribution not only in
nesthetized animals but also under physiologic conditions
n awake standing animals at rest.16
onclusion
-ILP, r-ILP, c-ILP, and BFO resulted in a significantly
igher doxorubicin uptake in the perfused lung than IV
dministration. The inter-animal variation and spatial het-
rogeneity of regional blood flow and drug uptake were
ore pronounced after “invasive” perfusion techniques than
bserved after IV drug administration in spontaneously
reathing animals. Future investigations to try to alleviate
his unequal perfusion pattern would include the stimulation
f beta-adrenergic receptors on pulmonary vascular smooth
uscles, pretreatment of the pulmonary circulation by va-
odilatators (prostacyclin, nitride oxide), avoidance of hy-
oxic vasoconstriction by hyperoxygenation before and
uring ILP, and recruitment of hypoperfused areas by in-
reasing the cardiac output with catecholamines before ILP.
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